Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy

Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy

BackgroundThe goal of this study was to identify potential predictive biomarkers for the therapeutic effect of infliximab (IFX) in Rheumatoid arthritis (RA) and explore the potential molecular mechanism of nonresponse to IFX treatment to achieve individualized treatment of RA.MethodsDifferential gen...

Full description

Bibliographic Details
Main Authors: Yongsong Cai, Ke Xu, Yirixiati Aihaiti, Zhijin Li, Qiling Yuan, Jing Xu, Haishi Zheng, Mingyi Yang, Bo Wang, Yanni Yang, Yin Yang, Peng Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
derlin-1
infliximab
predictive biomarker
autophagy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.795912/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.795912/full

Similar Items